Topics
~ Antitrust
~ Copyright
~ Database Protection
~ International Harmonization
~ Licensing
~ Litigation and Dispute Resolution
~ Patent Administration
~ Technology Transfer
~ Trade Secrets
~ Trademarks
Resources
~ Transcripts
~ Past Events
~ Publications
~ Upcoming Events
~ Web Sites
Sectors
~ Internet
~ Biotech/Pharma
~ E commerce
~ Agriculture
~ Business Methods
~ Software
|
|
Publications
Guiding Principles for University-Industry Endeavors
Following a National University-Industry Summit on April 25, 2006, the University-Industry Partnership Project, which sought to deliberate on the causes of, and potential solutions to, the difficulties facing universities and companies when attempting to work together, produced the report Guiding Principles for University-Industry Endeavors. The report is part of a national toolkit focused on strengthening university-industry research partnerships designed to support these collaborative relations.
Also found in: Business Methods | |
Living Studies in University-Industry Negotiations: Applications of the Guiding Principles for University-Industry Endeavors
The University-Industry Partnership Project, a collaboration of National Research Council of University Research Administrators, The National Academies' Government-University-Industry Research Administrators, and the Industrial Research Institute, convened in August 2003 to examine the frameworks for recasting the university-industry partnership. Members, collectively known as the University-Industry Congress, established three guiding principles for improving U-I partnerships. This report, the product of the National University-Industry Summit on April 25, 2006, defines approaches to foster university and industry partnerships and progressively minimize adverse outcomes of intellectual-property negotiation.
Also found in: Business Methods | |
Are Chemical Journals too Expensive and Inaccessible? On October 25-26, 2005, the Chemical Sciences Roundtable held a workshop to explore issues involving those who use and contribute to chemical literature, as well as those who publish and disseminate chemical journals. As a follow-up to the workshop, a summary was written to capture the presentations and discussions that occurred during the workshop. As a forum to discuss chemistry journals within the larger context of scientific, technical and medical journal publishing, the workshop covered whether chemists and chemical engineers have unique journal needs and, if so, whether these needs are being met in the current journal publishing environment. Workshop participants also tackled how open access publishing might be applied to the chemical literature, such as to provide authors more freedom to distribute their articles after publication and allowing free access to chemical literature archives.
| |
Access to Research Data in the 21st Century: (2002) "... The scientific community opposed the amendment on the grounds that it would invite intellectual property searches by industry and scientific competitors, jeopardize the privacy of research subjects, decrease the willingness of research subjects to participate in studies, expose research- ers to deliberate harassment, and increase costs and paperwork..." (page 2)
Also found in: Trade Secrets |
|
Networking Health: Prescriptions for the Internet Consumer health websites have garnered considerable media attention, but only begin to scratch the surface of the more pervasive transformations the Internet could bring to health and health care. Networking Health examines ways in which the Internet may become a routine part of health care delivery and payment, public health, health education, and biomedical research.
Also found in: Database Protection ~ Biotech/Pharma ~ Internet |
|
LC21: A Digital Strategy for the Library of Congress This report arises from the Library's own sense of its vulnerability and uncertainty at the dawn of the information age and attempts to respond closely to the institution's own sense of its mission. Accordingly, the Librarian of Congress asked the Computer Science and Telecommunications Board (CSTB) of the National Research Council (NRC) to conduct a study to provide strategic advice concerning the information technology path that LC should traverse over the coming decade.
Also found in: Copyright ~ Licensing ~ Business Methods |
|
The Internet's Coming of Age (2001), Table of Contents Key study in CSTB’s series of penetrating analyses of the evolution of the Internet, this report characterizes the Internet at the beginning of the 21st century, focusing on the evolution of key technical and business trends. It relates those trends to broader social and economic concerns, illuminating areas where public policy may become more important, while presenting arguments against premature or transplanted regulatory approaches. It provides a case study of the evolution of telephony over the Internet.
Also found in: Internet ~ E commerce |
|
Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health On November 17, 2005, the Academies' Science, Technology and Economic Policy (STEP) Board and the Science, Technology, and Law Committee (STL) released a joint report, "Patenting and Licensing of Genomic and Protein Inventions." The report (commissioned by the National Institutes of Health) was presented by Committee co-chairs Shirley Tilghman, President of Princeton University, and Roderick McKelvie, Covington and Burling (and retired Judge, Federal District Court of Delaware) at a public briefing at the National Academies in Washington, DC. . The report documents trends in patenting and licensing in several categories of genetic and protein research, differences between US practices and those in Europe and Japan, and the impact of these practices on academic and corporate research directed at identifying disease mechanisms and therapeutic and diagnostic discoveries. Recommendations are addressed to the NIH and other government and private research funding agencies; the courts and the US Patent and Trademark Office; Congress; and the research community at large. The report includes the results of a new survey of bench scientists on their experience with intellectual property acquisition and access and sharing of data and research materials. affecting the economic well being of the United States.
Also found in: Licensing ~ Patent Administration |
|
Patenting and Licensing of Genomic and Protein Inventions On November 17, 2005, the Academies' Science, Technology and Economic Policy (STEP) Board and the Science, Technology, and Law Committee (STL) released a joint report, "Patenting and Licensing of Genomic and Protein Inventions." The report (commissioned by the National Institutes of Health) was presented by Committee co-chairs Shirley Tilghman, President of Princeton University, and Roderick McKelvie, Covington and Burling (and retired Judge, Federal District Court of Delaware) at a public briefing at the National Academies in Washington, DC. .
The report documents trends in patenting and licensing in several categories of genetic and protein research, differences between US practices and those in Europe and Japan, and the impact of these practices on academic and corporate research directed at identifying disease mechanisms and therapeutic and diagnostic discoveries. Recommendations are addressed to the NIH and other government and private research funding agencies; the courts and the US Patent and Trademark Office; Congress; and the research community at large. The report includes the results of a new survey of bench scientists on their experience with intellectual property acquisition and access and sharing of data and research materials.
affecting the economic well being of the United States.
Also found in: Licensing ~ Patent Administration ~ Biotech/Pharma | |
Licensing Geographic Data and Services (2004) The Board on Earth Sciences and Resources published a report, Licensing Geographic Data and Services, available through National Academies Press. Licensing—rather than purchase—of geographic data and services is one of a number of data acquisition options for government. This report presents background on the geographic data marketplace; the licensing perspectives of government, industry, and academia; and legal, economic, and public interest underpinnings of the licensing debate. The report concludes with ideas that could address the broad range of stakeholder interests in geographic data. Also found in: Copyright ~ Licensing |
|
Nat'l Academies Press: Patents in the Knowledge-Based Economy his publication assembles nine original research studies commissioned by the STEP Board to inform judgments about some of the institutional and policy changes in the US patent system over the last 25 years. Included are papers assessing how the USPTO examination process affects the quality of issued patents, how the post-patent review system in the US ("patent re-examination") and Europe ("patent opposition") compare in operation, under what circumstances the benefits of an opposition system would outweigh the costs, what are the trends in patent litigation overall and in the semiconductor industry in particular, how and why the protection of software has shifted from copyrighting to patenting, what are the characteristics of Internet business method patents, and whether the proliferation of patents in biological research tools is inhibiting biomedical research. An introduction by the editors places this work in the context of other social science research on the patent system.
Also found in: Licensing ~ Litigation and Dispute Resolution ~ Patent Administration ~ Technology Transfer ~ Biotech/Pharma ~ Business Methods ~ Software |
|
A Patent System for the 21st Century, 2004 This report focuses on how well the system fulfills its mission of encouraging research, innovation, and the dissemination of knowledge and how it is adapting to rapid technological and economic changes. The panel concludes that the system has shown admirable flexibility in accommodating new technologies and reflecting the greater importance of intangible capital of all sorts. On the other hand, there is reason to be concerned about the quality of issued patents (whether they meet the statutory standards of novelty, utility, nonobviousness, and adequate written description), the resources available to the U.S. Patent and Trademark Office to keep up with the pace of change and volume of applications, features of U.S. law that inhibit the dissemination of information contained in patents and that raise the cost and uncertainty of litigation over patent validity and infringement, access to patented research technologies for basic non-commercial research, and redundancies and inconsistencies among national patent systems that raise the cost of global intellectual property protection.
Also found in: International Harmonization ~ Licensing ~ Litigation and Dispute Resolution ~ Patent Administration ~ Technology Transfer ~ Internet ~ Biotech/Pharma ~ Business Methods ~ Software |
|
Nat'l Academies Press: Electronic Scientific, Technical, and Medical Journal Publishing and Its Implications: Report of a Symposium The symposium took a broad look across the scientific, technical, and medical (STM) journal enterprise to provide a better understanding of the implications of electronic publishing of STM journals on the health of scientific, engineering, and medical research. The symposium brought together experts in STM publishing, both producers and users of these publications, to: 1) Identify the recent technical changes in publishing, and other factors, that influence the decisions of journal publishers to produce journals electronically; 2) Identify the needs of the scientific, engineering, and medical community as users of journals, whether electronic or printed; 3) Discuss the responses of not-for-profit and commercial STM publishers and of other stakeholders in the STM community to the opportunities and challenges posed by the shift to electronic publishing; and 4) Examine the spectrum of proposals that has been put forth to respond to the needs of users as the publishing industry shifts to electronic information production and dissemination.
Also found in: Database Protection |
|
Assessing the Value of Research in the Chemical Sciences This report captures the messages from a workshop that brought together research managers from government, industry, and academia to review and discuss the mechanisms that have been proposed or used to assess the value of chemical research. The workshop focused on the assessment procedures that have been or will be established within the various organizations that carry out or fund research activities, with particular attention to the Government Performance and Results Act (GPRA). It presents approaches and ideas from leaders in each area that were intended to identify new and useful ways of assessing the value and potential impact of research activities.
Also found in: Licensing |
|
Swords into Market Shares: Technology, Economics, and Security in the New Russia While researching this book, Glenn Schweitzer met four Moscow physicists who were trying to license Russian technology to western firms for product manufacture. During the worst times, they were reduced to driving taxis to keep things afloat. He asked them, will technological innovation have a discernible impact on the Russian economy in the coming decade? No, was the immediate reply. Are they right? In Swords into Market Shares, Schweitzer examines the roots of such pessimism and the prospects for Russia to prosper from its technology in the post-Soviet world. He explores the different visions of prosperity held by entrepreneurs, technologists, and government officials and goes on to examine the barriers to progress as Russia struggles to build a viable technology industry on its own terms. In accessible language, this book talks about technology's place within Russia's economy and its research and development infrastructure. Schweitzer looks at the impact of the Soviet legacy--central planning, lack of priorities, scant incentives for personal initiative--and the aftermath of the Russian financial meltdown of 1998.
Also found in: International Harmonization ~ Licensing ~ Technology Transfer ~ Business Methods |
|
Health Data in the Information Age: Use, Disclosure, and Privacy Regional health care databases are being established around the country with the goal of providing timely and useful information to policymakers, physicians, and patients. But their emergence is raising important and sometimes controversial questions about the collection, quality, and appropriate use of health care data.
Also found in: Database Protection |
|
Data for Science and Society: The Second National Conference on Scientific and Technical Data
| U.S. National Committee for CODATA
| National Research Council Many of the major scientific challenges we face today require the combined expertise from multiple disciplines. Complex issues such as the understanding of global climate change, the advance of biotechnology, and progress on various types of problems facing society can be addressed only by combining and using data that in the past have been available to researchers in one field only. In conjunction with several federal science agencies, the U.S. National Committee for CODATA organized the Second National Conference on Scientific and Technical Data: Data for Science and Society to address important multidisciplinary issues in managing and using scientific and technical (S&T) data and to improve the visibility of these issues nationally. The main focus was on promoting the availability and usefulness of S&T data to all users, both in research and in the broader society, using examples of ground-breaking and innovative applications and highly creative partnerships.
Also found in: Copyright ~ Database Protection ~ Licensing ~ Internet | |
Fostering Research on the Economic and Social Impacts of Information Technology This report provides a framework for studying a wide range of questions about how people use, influence, and are affected by the Internet and information technology generally. It is a guide to thinking about the implications of electronic commerce, the digitization of all kinds of information, and the notion of a digital divide. Among the areas outlined as candidates for research is intellectual property. Beginning with prepublication release in July 1998, it has been briefed to NSF and discussed in congressional testimony. The report contributed to the 1999 PITAC report, IT2 hearings, and the May 1999 Federal Digital Economy conference.
Also found in: Copyright ~ E commerce ~ Internet ~ Software |
|
Precision Agriculture in the 21st Century: This report provides an overview of the specific technologies and practices under the umbrella of precision agriculture, exploring the full implications of their adoption by farmers and agricultural managers. The volume discusses how precision agriculture could dramatically affect decisionmaking in irrigation, crop selection, pest management, environmental issues, and pricing and market conditions. It also examines the geographical dimensions--farm, regional, national--of precision agriculture and looks at how quickly and how widely the agricultural community can be expected to adopt the new information technologies.
Also found in: Copyright ~ International Harmonization ~ Technology Transfer |
|
Computing and the Humanities (ACLS Occasional Paper No. 41) A summary of a lively roundtable discussion held in March 1997 among computer scientists and humanists was published by the American Council of Learned Societies. It has become the most-requested ACLS occasional paper (see http://www.acls.org/op41-toc.htm). It has also become the inspiration for a series of activities, including the coordinated Building Blocks workshops and integrating conferences, under the aegis of the National Institute for a Networked Cultural Heritage and for the 2000-2002 CSTB project on Information Technology and Creativity, which will discuss intellectual property concerns. The original report and ensuing activities have explored areas of common interest among computer science and the humanities, with an interest in inspiring computer science research that relates to humanities challenges and opportunities.
Also found in: Copyright ~ Licensing ~ Internet | |
Rights and Responsibilities of Participants in Networked Communities (1994) The report illuminates, questions, and articulates difficult issues that arise in an era of increasing networked communications, and helps to lay a foundation for a more informed public debate and discussion of the rights and responsibilities of those who operate in this domain. Intellectual property is one of the sets of issues examined, with a range of perspectives outlined.
Also found in: Copyright ~ Internet |
|
Realizing the Information Future: (1994) This report describes why the Internet, with an Open Data Network (ODN) architecture, is as powerful a force as it has proven to be. It addresses the development and deployment of the information infrastructure, characterizing needs of the research and education communities in the context of commercialization and opportunities for the federal government to promote the ODN/Internet. Information policy, including intellectual property, is discussed as a concern influencing the development, use, and impacts of the Internet. Substantial dissemination activity was undertaken, engaging industry, government, and technical groups. This report also informed the development of The Unpredictable Certainty, released February 1996
Also found in: Copyright ~ Licensing ~ Internet |
|
Sharing Laboratory Resources: Genetically Altered Mice The remarkable success of molecular biology as a scientific enterprise over the last two decades is unqualified, but it has been accompanied by a complex phenomenon: the commercialization of its products. In some instances, such as the production of medically important materials by the biotechnology industry, we can point to commercialization as a vindication of public investment in science—a source of jobs, better health, and a competitive economy. But in other cases, the impulse to commercialize what science has produced raises troubling questions about conflicts of interests, the motivations of scientists, and even the legality of their actions. A workshop was held at the National Academy of Sciences on March 23 and 24, 1993 to consider genetically altered laboratory mice as a model with which to evaluate the elements that influence the sharing of scientific reagents, and this volume summarizes the views expressed by representatives of the community, academic institutions, the government, and several kinds of companies
Also found in: Licensing ~ Litigation and Dispute Resolution ~ Technology Transfer ~ Biotech/Pharma ~ Business Methods |
|
Biotechnology: Science, Engineering, and Ethical Challenges for the 21st Century Biotechnology-the manipulation of the basic building blocks of life-is rapidly advancing in laboratories around the world. It has become routine to refer to DNA fingerprints and genetically engineered foods.
Yet the "how to" of biotechnology is only the beginning. For every report of new therapies or better ways to produce food, there is a Jurassic Park scenario to remind us of the potential pitfalls.
Biotechnology raises serious issues for scientists and nonscientists alike: Who will decide what is safe? Who will have access to our personal genetic information? What are the risks when advanced science becomes big business?
In Biotechnology, experts from science, law, industry, and government explore a cross-section of emerging issues.
Also found in: International Harmonization ~ Licensing ~ Litigation and Dispute Resolution ~ Biotech/Pharma |
|
Biotechnology Unzipped: Promises and Realities "Biotechnology" may raise more hope and fear...revelation and confusion...excitement and alarm than any other term in today's headlines. In Biotechnology Unzipped, scientist and skilled science popularizer Eric Grace helps readers understand what biotechnology is and what implications it holds for all of us.
Grace offers a reader-friendly explanation of how we came to where we are--from the coining of the word "cell" in 1665 through Darwin's breakthrough insight on evolution and the unraveling of the DNA helix to the 1997 announcement of the cloning of Dolly the sheep.
Also found in: Biotech/Pharma |
|
Bits of Power: Issues in Global Access to Scientific Data Since Galileo corresponded with Kepler, the community of scientists has become increasingly international. A DNA sequence is as significant to a researcher in Novosibirsk as it is to one in Pasadena. And with the advent of electronic communications technology, these experts can share information within minutes. What are the consequences when more bits of scientific data cross more national borders and do it more swiftly than ever before? Bits of Power assesses the state of international exchange of data in the natural sciences, identifying strengths, weaknesses, and challenges.
Also found in: Copyright ~ Database Protection ~ International Harmonization ~ Licensing ~ Biotech/Pharma ~ Internet |
|
Orphans and Incentives: Developing Technology to Address Emerging Infections Infectious diseases remain a leading cause of prolonged illness, premature mortality, and soaring health costs. In the United States in 1995, infectious diseases were the third leading cause of death, right behind heart disease and cancer. Mortality is mounting over time, owing to HIV/AIDS, pneumonia, and septicemia, with drug resistance playing an ever-increasing role in each of these disease categories. This book, a report from a Forum on Emerging Infections workshop, focuses on product areas where returns from the market might be perceived as being too small or too complicated by other factors to compete in industrial portfolios with other demands for investment. Vaccines are quintessential examples of such products. The lessons learned fall into four areas, including what makes intersectoral collaboration a reality, the notion of a product life cycle, the implications of divergent sectoral mandates and concepts of risk, and the roles of advocacy and public education. The summary contains an examination of the Children's Vaccine Initiative and other models, an industry perspective on the emerging infections agenda, and legal and regulatory issues.
Also found in: Biotech/Pharma |
|
U.S. Industry in 2000: Studies in Competitive Performance U.S. industry faced a gloomy outlook in the late 1980s. Then, industrial performance improved dramatically through the 1990s and appears pervasively brighter today. A look at any group of industries, however, reveals important differences in the factors behind the resurgence--in industry structure and strategy, research performance, and location of activities--as well as similarities in the national policy environment, impact of information technology, and other factors.
Also found in: International Harmonization ~ Biotech/Pharma ~ Software |
|
The Digital Dilemma: Intellectual Property in the Information Age This book presents the multiple facets of digitized intellectual property, defining terms, identifying key issues, and exploring alternatives. It follows the complex threads of law, business, incentives to creators, the American tradition of access to information, the international context, and the nature of human behavior. Technology is explored for its ability to transfer content and its potential to protect intellectual property rights. The book proposes research and policy recommendations as well as principles for policymaking.
Also found in: Copyright ~ Database Protection ~ Licensing ~ E commerce ~ Internet ~ Software |
|
Agricultural Crop Issues and Policies This anchor volume to the series Managing Global Genetic Resources examines the structure that underlies efforts to preserve genetic material, including the worldwide network of genetic collections; the role of biotechnology; and a host of issues that surround management and use.
Among the topics explored are in situ versus ex situ conservation, management of very large collections of genetic material, problems of quarantine, the controversy over ownership or copyright of genetic material, and more.
Also found in: Copyright ~ Biotech/Pharma |
|
Technology Commercialization: Russian Challenges, American Lessons This collection of papers—by American and Russian specialists—addresses a variety of legal, regulatory, institutional, and financial issues that can promote or hinder technology commercialization. The book is the result of a series of workshops organized by the National Research Council with the Russian Academy of Sciences on commercialization of technologies, particularly those developed at research and educational institutions.
Technology Commercialization concludes with a list of actions, programs, and policies which warrant further consideration as Russia tries to improve the success of technology commercialization. This book will be of interest to those concerned with small-business development in post-communist states, university technology management, and comparative technology commercialization.
Also found in: Licensing ~ Patent Administration ~ Trademarks ~ Technology Transfer ~ Business Methods |
|
The Children's Vaccine Initiative: Achieving the Vision The Children's Vaccine Initiative is an international endeavor to ensure that children throughout the world are immunized. This book notes that one of the best opportunities to address the growing problem of immunization in the United States and to improve the health of children in developing countries lies in marshaling the vaccine development and production efforts in the United States and abroad. The report contains information on the nature and status of vaccine development and production efforts in the United States and abroad, and it recommends ways to enhance participation in the International Children's Vaccine Initiative. Appendix A of the report details relevant intellectual property rights law.
Also found in: Licensing ~ Litigation and Dispute Resolution ~ Patent Administration ~ Biotech/Pharma |
|
Conflict and Cooperation in National Competition for High-Technology Industry This unique volume contains a powerful set of recommendations on issues at the center of international discussions on investment, trade, and technology policy. They take into account the globalization of industrial activity and the special characteristics of high-technology industries while recognizing the continued policy role of national governments. The report identifies the rationale for promotional measures for high-technology industries, delineates sources of friction among the leading industrial countries, and proposes policies to enhance international cooperation and strengthen the multilateral trading regime. It also examines the factors driving collaboration among otherwise competing firms and national programs, highlights the need to develop principles of equitable public and private international cooperation, and emphasizes the linkage between investment, government procurement, and other trade policies and prospects for enhanced international cooperation.
Also found in: Licensing ~ Technology Transfer ~ Business Methods |
|
Isotopes for Medicine and the Life Sciences Radioactive isotopes and enriched stable isotopes are used widely in medicine, agriculture, industry, and science, where their application allows us to perform many tasks more accurately, more simply, less expensively, and more quickly than would otherwise be possible. Indeed, in many cases--for example, biological tracers--there is no alternative. In a stellar example of "technology transfer" that began before the term was popular, the Department of Energy (DOE) and its predecessors has supported the development and application of isotopes and their transfer to the private sector. The DOE is now at an important crossroads: Isotope production has suffered as support for DOE's laboratories has declined. In response to a DOE request, this book is an intensive examination of isotope production and availability, including the education and training of those who will be needed to sustain the flow of radioactive and stable materials from their sources to the laboratories and medical care facilities in which they are used. Chapters include an examination of enriched stable isotopes; reactor and accelerator-produced radionuclides; partnerships among industries, national laboratories, and universities; and national isotope policy.
Also found in: Technology Transfer ~ Biotech/Pharma |
|
High-Stakes Aviation: U.S.-Japan Technology Linkages in Transport Aircraft The third in a series of sector-specific assessments of U.S.-Japan technology linkages, this book examines U.S.-Japan relationships that develop or transfer aircraft technology, the motivations of participating organizations, and the impacts on U.S. and Japanese capabilities. Incorporating detailed accounts of the business and technology aspects of U.S.-Japan aircraft alliances, the volume also describes the U.S. and Japanese policy contexts, presents alternative scenarios for the future and outlines how linkages with Japan can be leveraged as part of a strategy to reenergize U.S. leadership in this critical industry.
Also found in: Technology Transfer ~ Business Methods |
|
Marine Aquaculture: Opportunities for Growth This report examines the obstacles to developing marine aquaculture in the United States and offers specific recommendations for technology and policy strategies to encourage this industry. The volume provides a wealth of information on the status of marine aquaculture--including comparisons between U.S. and foreign approaches to policy and technology and of the diverse species under culture
Also found in: Technology Transfer |
|
Putting Biotechnology to Work: Bioprocess Engineering The ability of the United States to sustain a dominant global position in biotechnology lies in maintaining its primacy in basic life-science research and developing a strong resource base for bioprocess engineering and bioproduct manufacturing. This report examines the status of bioprocessing and biotechnology in the United States; current bioprocess technology, products, and opportunities; and challenges of the future and what must be done to meet those challenges. It gives recommendations for action to provide suitable incentives to establish a national program in bioprocess-engineering research, development, education, and technology transfer.
Also found in: Licensing ~ Technology Transfer ~ Biotech/Pharma |
|

| |
| search within report:
| |
|
|
|